Shape Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
SEATTLE, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape^TX), a biotechnology company creating the future of RNA technologies, today announced that Francois Vigneault, PhD., co-founder and Chief Executive Officer, will present virtually at the 40^th Annual J.P. Morgan Healthcare Conference. Dr. Vigneault will discuss how the Shape^TX portfolio of RNA platform technologies will enable and accelerate the emerging field of programmable RNA medicines.The presentation will take place on Monday, January 10 at 4:30 p.m. ET.
*About Shape Therapeutics Inc*
Shape Therapeutics is a biotechnology company creating the future of RNA technologies. The Shape^TX gene therapy platform is comprised of a suite of RNA payload technologies (RNAskip™, RNAfix™, RNAswap™), tissue-specific viral delivery technology (AAVid™), and SquareBio, a solution for scalable gene therapy manufacturing. At the core of these technologies is the Shape^TX AI engine, where data drives decisions today to enable the gene therapies of tomorrow. Shape^TX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Shape Life! shapetx.com
Contact
Investors & Media
Cindy Fung, PhD
cindy@shaptetx.com